Issue 134 unplanned pregnancy pku

Page 1

FOCUS ON PKU

Rachel Wilson RD Clinical Science Dietitian, Vitaflo International Ltd After seven years in the NHS, nearly four years within IEM, Rachel joined Vitaflo in January 2017 where she now develops education literature, study events and clinical trials. Written in collaboration with: Charlotte Ellerton RD, Metabolic Dietetic Practitioner, Charles Dent Metabolic Unit, UCLH Charlotte has been working in IEM for nearly nine years. She is particularly interested in pregnancy in IEM and diabetes. Current research areas include maternal PKU and glycogen storage disorders.

REFERENCES For full article references please CLICK HERE . . .

UNPLANNED PREGNANCY IN WOMEN WITH PHENYLKETONURIA (PKU): A DIETETIC EMERGENCY The aim of this article is to provide a summary of PKU and its management during preconception and pregnancy, known as maternal PKU (mPKU), and to offer guidance on how to dietetically manage an individual with PKU who is planning a pregnancy, or is pregnant. Expert dietetic advice is essential for the management of PKU during preconception and pregnancy. High levels of phenylalanine (Phe) levels are teratogenic, and can result in irreversible physical and cognitive damage of the foetus.1,2 From a young age, females with PKU are taught about the need for a strict PKU diet when they are ready to have a baby of their own. As with many people with chronic conditions, individuals with PKU can struggle to attend outpatient clinics, adhere to medical and dietary advice (particularly as teenagers and young adults), and may become lost to follow-up to the specialist metabolic services.3,4 These individuals can present to their general practitioner (GP) when planning, or upon discovery of, a pregnancy. Their GP may refer these individuals to their local dietetic service for specialist dietary advice. If you received such a referral, would you know what to do? WHAT IS PKU?

PKU is an inborn error of Phe metabolism. Without early dietary management, the amino acid Phe and its metabolites accumulate to toxic levels, and cause progressive and irreversible neurological impairment.5 PKU effects approximately one in 10,000 people in the UK. It was the first

metabolic condition to be targeted by newborn screening (NBS) in the UK in the late 1960s. Individuals identified and managed following NBS can expect to grow and develop similarly to their peers, attend mainstream schools, graduate from University, and live independently with jobs and families of their own.5 MANAGEMENT OF PKU

PKU is managed with individualised dietary advice to achieve and maintain target Phe levels and optimal nutritional intakes. Dietary management requires: • a severe restriction of all dietary protein- requiring prescription-only low protein (LP) foods to provide energy, bulk and variety; • a prescription of protein substitutes (PS) - these contain all the other amino acids except Phe and most also contain micronutrients that would otherwise be insufficient in a protein restricted diet, including iron, vitamin B12, calcium, iodine, vitamin D, zinc and DHA. Target Phe levels:5 • 120-360µmol/L from birth to 12 years • 120-600µmol/L from 13 years onwards • 120-360µmol/L during preconception and pregnancy www.NHDmag.com May 2018 - Issue 134

49


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Issue 134 unplanned pregnancy pku by NH Publishing Ltd - Issuu